← back to search

Caihong Li

Fuzhou University · CN
Area of research
Cancer Research · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include MicroRNA in disease regulation, Corneal surgery and disorders, COVID-19 Clinical Research Studies, and Mycotoxins in Agriculture and Food.
h-index
29
citations
8,468
works
171
NIH funding
primary concept
Medicine
email

Recent publications

Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension
Circulation 2024cited by 32position: middledoi
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
The Lancet 2023cited by 889position: middledoi
Changes in Gut Microbiota and Metabolites in Papillary Thyroid Carcinoma Patients Following Radioactive Iodine Therapy
International Journal of General Medicine 2023cited by 19position: middledoi
Loss of endothelial CFTR drives barrier failure and edema formation in lung infection and can be targeted by CFTR potentiation
Science Translational Medicine 2022cited by 27position: middledoi
Differential distribution and prognostic value of CD4+ T cell subsets before and after radioactive iodine therapy in differentiated thyroid cancer with varied curative outcomes
Frontiers in Immunology 2022cited by 7position: middledoi
Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma
Frontiers in Immunology 2022cited by 3position: middledoi
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
The Lancet 2021cited by 4,274position: middledoi
Bi-allelic Missense Pathogenic Variants in TRIP13 Cause Female Infertility Characterized by Oocyte Maturation Arrest
The American Journal of Human Genetics 2020cited by 136position: middledoi
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: A multi-center study from China
Research Square 2020cited by 0position: middledoi
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: A multi-center study from China
Research Square 2020cited by 0position: middledoi
Rho-Associated Kinase Inhibitors Promote Microglial Uptake Via the ERK Signaling Pathway
Neuroscience Bulletin 2016cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yan Xue · The First Affiliated Hospital, Sun Yat-sen University2 papers (2022–2022)Di Fan · The University of Texas Southwestern Medical Center2 papers (2022–2022)Keyi Lu · Shanxi Medical University2 papers (2022–2022)Li‐Xiang Wu · Shanxi Medical University2 papers (2022–2022)Zhiyong Shi · Shanxi Medical University2 papers (2022–2022)Wolfgang M. Kuebler · University of Toronto2 papers (2022–2024) · 2 papers (2022–2022)Zhe-Hao Cheng · Shanxi Medical University2 papers (2022–2022)Zhi-Fang Wu · Shanxi Medical University2 papers (2022–2022)Lasti Erfinanda · Humboldt-Universität zu Berlin2 papers (2022–2024)Xiaofeng Li · Shandong University2 papers (2022–2022)Haiyan Liu · National University of Singapore2 papers (2022–2022)Minjie Xie · Ministry of Education of the People's Republic of China1 papers (2016–2016)Sijin Li · Shanxi Medical University1 papers (2022–2022)Sijin Li · Xuzhou Medical College1 papers (2022–2022)Sijin Li · Shanxi Medical University1 papers (2023–2023)Zhiyuan Yu · Ministry of Education of the People's Republic of China1 papers (2016–2016)Wanting Li · South China Agricultural University1 papers (2023–2023)Jie Dong · National Institutes of Health1 papers (2020–2020)Jing Fu · Kunming Medical University1 papers (2020–2020)